StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
VNRXVOLITIONRX LTD
stockpulse.co.kr
NYSE
$0.1741▲ 0.87%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $2.0MShares out 11.6M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

18
  • 1d agoAfter-hours26.10.24 06:00
    4Ownership#●●●#●●●

    VOLITIONRX LTD

    Insider Ann-Louise Batchelor of VolitionRX Ltd reported a change in beneficial ownership of company securities on October 21, 2026. This filing serves as a Form 4 statement regarding the insider's stock holdings.…more

    $0.1741+0.87%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 9.30After-hours26.10.01 06:00
    4Ownership

    VOLITIONRX LTD

    VolitionRx Ltd insider Gael Forterre filed a Form 4 statement of changes in beneficial ownership of securities on September 28, 2026. This filing serves as an official record of the insider's equity transaction.…more

    $0.1741+0.87%vs prev close
    View filingShare
  • 9.30After-hours26.10.01 06:00
    4Ownership

    VOLITIONRX LTD

    Insider Michel Gaetan of VolitionRx Ltd filed a Form 4 report on September 30, 2026, regarding changes in beneficial ownership of securities as of September 28, 2026.…more

    $0.1741+0.87%vs prev close
    View filingShare

17 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire
  • 9.17Pre-market26.09.17 21:19
    #●●●#●●●

    VolitionRx Launches DETECSEPS Sepsis Detection Project With $7.3M French Funding…more

    VolitionRx has officially launched the DETECSEPS project, a sepsis early detection initiative backed by approximately $7.3 million in French government funding. The company will provide its Nu.Q NETs assay as the exclusive biomarker for this collaborative research effort.…more

    $0.1741+0.87%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    ShareBenzinga
  • 9.14Pre-market26.09.14 21:20

    ●●●●●●●● ●●●●● ●●●●●●

    VolitionRx has fully repaid its $7.5 million convertible promissory note held by Lind Global Asset Management in cash. While all obligations related to this specific note have been satisfied, other outstanding debt obligations remain.…more

    $0.1741+0.87%vs prev close
    ShareBenzinga
  • 8.28After-hours26.08.29 05:26

    ●●●●●●●● ●●●●● ●●●●●●

    VolitionRx has filed a prospectus with the SEC for the sale of 10 million common shares by existing shareholders. This offering involves secondary shares rather than new issuance, though it may still impact market liquidity and share price.…more

    $0.1741+0.87%vs prev close
    ShareBenzinga

2 more news items

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →